معرفی
Dr. Lihi Atzmony Maoz is an Assistant Professor at Yale School of Medicine's Department of Dermatology. She specializes in treating advanced skin cancer and genetic skin diseases, providing comprehensive care for a wide range of dermatological conditions.
Education:
- BSc in Medical Science, Tel Aviv University (2006)
- MD, Tel-Aviv University (2012)
- Internship, Tel Aviv Sourasky Medical Center
- Residency, Rabin Medical Center (2017)
- Post Doctoral Fellowship, Yale University (2019)
Dr. Atzmony Maoz's research primarily focuses on the pathogenesis and treatment of genetic skin diseases, particularly Darier Disease and Porokeratosis, as well as exploring new treatment modalities for non-melanoma skin cancer. Her work bridges clinical dermatology with cutting-edge genetic research, investigating somatic mutations and molecular pathways underlying rare skin disorders. She has published extensively on topics including Darier disease, bullous pemphigoid, vascular malformations, and novel therapeutic approaches for genetic skin conditions.
Analysis of Dr. Atzmony Maoz's recent publications reveals a strong emphasis on genetic dermatology, with particular focus on somatic mutations in conditions like Darier disease. Her research combines clinical observations with molecular analysis, often identifying specific genetic variants that underlie persistent skin lesions. She has also contributed to pharmacological research, investigating novel treatments like TRPV3 inhibitors for keratoderma and statins for skin cancer.
Dr. Atzmony Maoz actively collaborates with prominent researchers at Yale including Dr. Keith Choate, Dr. Dhanpat Jain, and Dr. Jonathan Leventhal, demonstrating strong institutional connections within the dermatology and genetics research communities.
Clinically, she treats patients at multiple Yale Medicine Dermatology locations in Connecticut, specializing in advanced skin cancer and genetic skin diseases while advancing knowledge through her research activities.